Obermeyer Wealth Partners’s Elevance Health ELV Stock Holding History

Obermeyer Wealth Partners’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-7,412	Closed	-$1.03M	–	127
2015 Q4	$1.03M	Sell	7,412 -108,257	-94%	-$14.9M	0.09%	51
2015 Q3	$16.2M	Sell	115,669 -4,729	-4%	-$711K	1.71%	21
2015 Q2	$19.8M	Buy	120,398 +42	+0%	+$6.71K	1.69%	21
2015 Q1	$18.6M	Sell	120,356 -776	-0.6%	-$110K	1.52%	26
2014 Q4	$15.2M	Sell	121,132 -1,008	-0.8%	-$125K	1.38%	28
2014 Q3	$14.6M	Sell	122,140 -750	-0.6%	-$86K	3.59%	10
2014 Q2	$13.2M	Sell	122,890 -316	-0.3%	-$32.6K	3.22%	11
2014 Q1	$12.3M	Sell	123,206 -2,284	-2%	-$207K	3.06%	16
2013 Q4	$11.6M	Buy	125,490 +870	+0.7%	+$77.3K	2.96%	18
2013 Q3	$10.4M	Buy	+124,620	New	+$10.7M	2.92%	20

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Obermeyer Wealth Partners's ELV Position: Q1 2016 in Review

Obermeyer Wealth Partners sold out of Elevance Health (ELV) in Q1 2016, closing a stake of 7,412 shares — an estimated $1.03M sold.

Obermeyer Wealth Partners first reported a position in ELV in Q3 2013 and held it in 10 quarters. The position peaked at $19.8M in Q2 2015. 772 funds tracked by Wall St. Rank hold ELV as of Q1 2016.

Obermeyer Wealth Partners reported no remaining Elevance Health position as of Q1 2016 after selling out during the quarter.
Obermeyer Wealth Partners sold 7,412 Elevance Health shares in Q1 2016, an estimated $1.03M.
Obermeyer Wealth Partners first reported a position in Elevance Health in Q3 2013 and held it in 10 quarters.
Obermeyer Wealth Partners's Elevance Health position peaked at $19.8M in Q2 2015.
772 funds tracked by Wall St. Rank held Elevance Health as of Q1 2016.

Based on Obermeyer Wealth Partners's 13F filing for Q1 2016, filed 11 May 2016.